UROGENITAL NEOPLASMS
Clinical trials for UROGENITAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UROGENITAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare penile cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 27 men with advanced penile cancer that has spread to lymph nodes. The goal is to see if this treatment can completely eliminate the cancer before surgery. Pa…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 16, 2026 23:51 UTC
-
New radioactive drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new radioactive drug (177Lu-rhPSMA-10.1) in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to find the safest and most effective dose to shrink tumors or lower PSA levels. About 82 men will take part acr…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Could a dual immunotherapy spare the bladder in cancer patients?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab with or without relatlimab) before surgery can eliminate bladder cancer completely, allowing some patients to avoid bladder removal. About 90 adults with stage II-IIIa bladder cancer will receive the drugs and the…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug combo trial offers hope for Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new drug called pocenbrodib, either by itself or combined with other treatments, in people with a type of advanced prostate cancer that no longer responds to hormone therapy. The goal is to find the safest dose and see if it helps shrink tumors or lower PSA lev…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug combo aims to boost immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests two drugs, bintrafusp alfa and PDS01ADC, alone or with targeted radiation, in adults with metastatic bladder, kidney, or other non-prostate genitourinary cancers. The goal is to see if the combination helps the immune system fight cancer better. About…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New scan could spot kidney cancer more accurately
Diagnosis Recruiting nowThis study aims to see if a new imaging agent called [18F]RCCB6 can improve the detection of kidney cancer, especially the most common type (clear cell renal cell carcinoma). Researchers will enroll 300 adults with confirmed or suspected kidney cancer to measure how well the trac…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Apr 30, 2026 15:52 UTC
-
New test could help doctors choose the right bladder cancer treatment
Knowledge-focused Recruiting nowThis study is testing a new lab method called SPHERTEST to see if it can predict whether immunotherapy will work for people with advanced bladder cancer. Researchers will take blood and tumor samples from 32 patients to create a 3D cell model and measure how the immune system att…
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Massive study tracks rare urinary cancers to unlock treatment secrets
Knowledge-focused Recruiting nowThis study follows 1,100 adults with common and rare urinary tract cancers (like bladder, kidney, or testicular cancer) over their lifetime. Researchers collect medical records, blood, urine, and tumor samples to understand how these cancers behave and respond to treatments. The …
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC